7.5 mg tirzepatide TIRZEE 7.5MG/0.5ML PEN 1'S 7.5 mg Tirzepatide ( MOUNJARO)

Zhang and Hashimoto, 2019)

Bemis, K

Retatrutide is a novel triagonist peptide that simultaneously targets three critical metabolic receptors: Glucagon-like peptide-1 (GLP-1) Glucose-dependent insulinotropic polypeptide (GIP) Glucagon Originally developed for clinical research into obesity and metabolic disorders, retatrutide is designed to support extensive scientific exploration of: Weight reduction Improved glucose management Enhanced metabolic function What Key Benefits Does Retatrutide Offer

In turn, this GI slowdown can cause a domino effect that slows down waste elimination

doi: 10.1002/mnfr.201900732 63 KeH.LiF.DengW.LiZ.WangS.LvP.et al

Orskov C, Bersani M, Johnsen AH, Hojrup P, and Holst JJ